Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2000, p. 85-89, Vol. 38, No. 1
Organon Teknika Corporation, Durham, North
Carolina1; Sacramento Medical
Foundation, Sacramento, California2;
North Shore University Hospital-New York University School of
Medicine, Manhasset, New York3; and
Massachusetts General Hospital, Boston,
Massachusetts4
Received 16 June 1999/Returned for modification 18 August
1999/Accepted 27 September 1999
The relationship between specimen input volume and the frequency of
reported human immunodeficiency virus type 1 (HIV-1) RNA copy numbers
by nucleic acid amplification technology (the NASBA HIV-1 RNA QT
system) was investigated. Results obtained with both clinical specimens
and dilution panels indicated that both the absolute number of reported
results and the reported HIV-1 RNA copy number were directly
proportional to the specimen input volumes evaluated (0.1, 0.5, and 1.0 ml). Conversion of the reported HIV-1 RNA copy numbers to a constant
1.0-ml volume indicated that the numerical relationship among the
specimen input volumes and the HIV-1 RNA copy numbers was
multiplicative. The HIV-1 RNA copy numbers reported for the 0.5-ml
input volume were approximately 5-fold increased over those reported
for the 0.1-ml input volume, and those reported for the 1.0-ml input
volume were 10-fold increased over those reported for the 0.1-ml input
volume. For the specimen input volumes investigated, a common linear
range of 264 to 5,400,000 HIV-1 RNA copies was observed. The use of
increased specimen input volumes did not result in a loss of assay
specificity, as the results reported for specimens from 50 seronegative
blood donors were negative at all three specimen input volumes. In
conclusion, an increase in the input volume of specimens analyzed by
nucleic acid amplification technology can be useful for the enhanced
detection of HIV-1 RNA.
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Relationship of Incremental Specimen Volumes and
Enhanced Detection of Human Immunodeficiency Virus Type 1 RNA with
Nucleic Acid Amplification Technology
*
Corresponding author. Mailing address: Organon Teknika
Corp., 100 Akzo Ave., Durham, NC 27712. Phone: (919) 620-2392. Fax: (919) 620-2324. E-mail: dwitt{at}orgtek.com.
Present address: Emory University Hospital, Atlanta, Ga.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|